839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors

839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors

Bibliographic Details
Main Authors:	Amanda G Powell, Indu Venugopal, Morgan N DeLong, Shelby Knoche, Michael J McGuire, Kathlynn C Brown
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

190 Utilizing a peptide-based approach to target and evaluate novel biomarker Neu5Gc Sialyl Lewis A in cancer
by: Indu Venugopal, et al.
Published: (2023-11-01)

A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density.
by: Bethany Powell Gray, et al.
Published: (2013-01-01)

Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy
by: Guang-Long Ma, et al.
Published: (2023-04-01)

Radiation recall pneumonitis from immune checkpoint inhibitors after extra pulmonary radiation
by: Leslie E. Kao, et al.
Published: (2023-10-01)

Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin
by: Curtis A. Allred, et al.
Published: (2023-01-01)

Intralesional administration of VAX014 facilitates in situ immunization and potentiates immune checkpoint blockade in immunologically cold tumors
by: Shingo Tsuji, et al.
Published: (2023-06-01)

839 Microbiota-specific T follicular helper cells drive tertiary lymphoid structure formation and anti-tumor immunity in colorectal cancer
by: Dario Vignali, et al.
Published: (2021-11-01)

Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation
by: Lucile Dumolard, et al.
Published: (2023-03-01)

RECALLING IMMUNE RESPONSES POST VISCERAL LEISHMANIASIS
by: B. Singh, et al.
Published: (2023-05-01)

Pyoderma Gangrenosum Following Initiation of Immune Checkpoint Inhibitor Therapy
by: Macartney E Welborn, et al.
Published: (2018-10-01)

Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade
by: Liam F. Spurr, et al.
Published: (2024-01-01)

Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer
by: Xiaotong Lu, et al.
Published: (2022-06-01)

Mitochondrial Dysfunction and the Aging Immune System
by: Peter J. McGuire
Published: (2019-05-01)

CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy
by: Delong Liu
Published: (2019-11-01)

Tumour-immune dynamics with an immune checkpoint inhibitor
by: Elpiniki Nikolopoulou, et al.
Published: (2018-06-01)

Radiation recall pneumonitis triggered by an immune checkpoint inhibitor following re-irradiation in a lung cancer patient: a case report
by: Xianghua Ye, et al.
Published: (2022-02-01)

Metabolic Adjustments following Glutaminase Inhibition by CB-839 in Glioblastoma Cell Lines
by: Juan De los Santos-Jiménez, et al.
Published: (2023-01-01)

From immune checkpoints to therapies: understanding immune checkpoint regulation and the influence of natural products and traditional medicine on immune checkpoint and immunotherapy in lung cancer
by: Yibin Zhou, et al.
Published: (2024-02-01)

Emerging Immune-Monitoring System for Immune Checkpoint Inhibitors
by: Kazuyuki Hamada, et al.
Published: (2022-08-01)

Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas
by: Virginia Laspidea, et al.
Published: (2022-04-01)

Biomarkers for immune checkpoint blockers
by: Kirsty Wienand, et al.
Published: (2018-06-01)

Immune Checkpoints in Viral Infections
by: Huiming Cai, et al.
Published: (2020-09-01)

Immune Checkpoint Inhibitors and the Heart
by: Diana Larisa Mocan-Hognogi, et al.
Published: (2021-09-01)

Higher recall in metagenomic sequence classification exploiting overlapping reads
by: Samuele Girotto, et al.
Published: (2017-12-01)

Immune Checkpoints Contribute Corneal Immune Privilege: Implications for Dry Eye Associated with Checkpoint Inhibitors
by: Junko Hori, et al.
Published: (2020-05-01)

The Role of Immune Checkpoint Receptors in Regulating Immune Reactivity in Lupus
by: Kun-Lin Lu, et al.
Published: (2019-10-01)

Association of Immune-Mediated Cerebellitis With Immune Checkpoint Inhibitor Therapy
by: Joanna Zurko, MD, et al.
Published: (2018-03-01)

Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity
by: Wei Xie, et al.
Published: (2019-11-01)

CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis
by: Lutgens, E, et al.
Published: (2023)

Childhood Immunization in Ethiopia: Accuracy of Maternal Recall Compared to Vaccination Cards
by: Julia M. Porth, et al.
Published: (2019-06-01)

Barriers to the use of reminder/recall interventions for immunizations: a systematic review
by: Pereira Jennifer A, et al.
Published: (2012-12-01)

Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
by: Baoyuan Zhang, et al.
Published: (2024-02-01)

P839: A curated research catalogue of structural variation detected by optical genome mapping
by: Andy Wing Chun Pang, et al.
Published: (2024-01-01)

Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal
by: Vítor Borges, et al.
Published: (2020-01-01)

Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia
by: Natalia Timofeeva, et al.
Published: (2023-05-01)

A convergence analysis of an iterative algorithm of order \(1.839\ldots\) under weak assumptions
by: Ioannis K. Argyros
Published: (2003-08-01)

A convergence analysis of an iterative algorithm of order \(1.839\ldots\) under weak assumptions
by: Ioannis K. Argyros
Published: (2003-08-01)

839 Transcriptomic profiling of T-cell populations in non-muscle invasive and muscle invasive bladder cancer
by: Peter Ellmark, et al.
Published: (2020-11-01)

Immune checkpoints as therapeutic targets in autoimmunity
by: Paluch, C, et al.
Published: (2018)

Immune Checkpoint Inhibition in Hodgkin Lymphoma
by: Ryan H. Moy, et al.
Published: (2018-02-01)